We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock
NURO

Delisted

NURO was delisted on the 1st of May, 2025.

Back to rankings

17 hedge funds and large institutions have $3.11M invested in NeuroMetrix, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

19% less funds holding

Funds holding: 21 → 17 (-4)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

56% less capital invested

Capital invested by funds: $7.13M → $3.11M (-$4.02M)

Holders
17
Holders Change
-4
Holders Change %
-19.05%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
3
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$575K
2
Morgan Stanley
Morgan Stanley
New York
+$97.6K
3
Osaic Holdings
Osaic Holdings
Arizona
+$72.4K
4
BlackRock
BlackRock
New York
+$59.8K
5
State Street
State Street
Massachusetts
+$50.3K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$599K
2
SSA
Schonfeld Strategic Advisors
New York
-$309K
3
VF
Virtu Financial
New York
-$237K
4
Squarepoint
Squarepoint
New York
-$220K
5
SFI
Susquehanna Fundamental Investments
Pennsylvania
-$144K

NURO Hedge Fund Activity: Q4 2021 in Review

17 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q4 2021, worth a combined $3.11M — down 56% from $7.13M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NURO and 4 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 7 added.

The largest buyer was Renaissance Technologies, adding an estimated $575K. The largest seller was Vanguard Group, cutting an estimated $599K.

  • 17 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q4 2021, down from 21 in Q3 2021.
  • Funds reported $3.11M of NeuroMetrix, Inc. Common Stock stock for Q4 2021, down 56% quarter-over-quarter.
  • 4 funds opened new NeuroMetrix, Inc. Common Stock positions in Q4 2021 and 8 closed out, a net change of -4 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q4 2021 was Renaissance Technologies, an estimated $575K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q4 2021 was Vanguard Group, an estimated $599K sold.

Based on aggregated 13F filings for Q4 2021.